WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Stock Ownership - Who owns Abeona Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Abeona Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark AlvinoDirector2026-09-0115,000$5.86
$87.96kSell
Joseph Walter VazzanoCFO2026-07-211,478$6.53
$9.65kSell
Joseph Walter VazzanoChief Financial Officer2026-07-0924,880$6.96
$173.26kSell
Brendan M. OmalleySVP Chief Legal Officer2026-07-0912,050$6.96
$83.92kSell
Madhav VasanthavadaChief Commercial Officer2026-07-0912,606$6.96
$87.79kSell
Vishwas SeshadriChief Executive Officer2026-07-0967,971$6.96
$473.35kSell
Leila AllandDirector2026-06-3011,000$5.92
$65.09kSell
Madhav VasanthavadaChief Commercial Officer2026-06-16222$5.67
$1.26kSell
Christine Berni SilversteinDirector2026-06-1518,160$5.71
$103.69kSell
Joseph Walter VazzanoChief Financial Officer2026-06-0925,646$5.39
$138.28kSell

1 of 4

ABEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABEO insiders and whales buy or sell their stock.

ABEO Shareholders

What type of owners hold Abeona Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sco Capital Partners LLC25.16%14,390,007$77.71MInsider
Steven H. Rouhandeh24.44%13,977,076$75.48MInsider
Adage Capital Partners GP LLC5.68%3,249,994$17.55MInsider
Ayer Capital Management LP4.22%2,413,163$13.03MInsider
B. Davis Jeffrey3.37%1,926,170$10.40MInsider
Vishwas Seshadri2.28%1,306,108$7.05MInsider
Oracle Associates LLC1.57%900,400$4.86MInsider
Mark J. Ahn0.86%493,182$2.66MInsider
Joseph Walter Vazzano0.86%492,079$2.66MInsider
Brendan M. Omalley0.75%427,953$2.31MInsider

1 of 3

ABEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABEO0.07%75.06%Net SellingNet Selling
PRLD0.06%51.13%Net Buying
EVMN0.10%58.21%Net BuyingNet Buying
EYPT0.05%99.95%Net SellingNet Buying
VNDA0.08%69.36%Net Selling
View Top Biotech Stocks

Abeona Therapeutics Stock Ownership FAQ

Who owns Abeona Therapeutics?

Abeona Therapeutics (NASDAQ: ABEO) is owned by 0.07% institutional shareholders, 75.06% Abeona Therapeutics insiders, and 24.88% retail investors. Sco Capital Partners LLC is the largest individual Abeona Therapeutics shareholder, owning 14.39M shares representing 25.16% of the company. Sco Capital Partners LLC's Abeona Therapeutics shares are currently valued at $77.71M.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.